SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-18-174174
Filing Date
2018-05-25
Accepted
2018-05-25 06:09:42
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d536574d424b5.htm 424B5 384837
2 GRAPHIC g536574g14v17.jpg GRAPHIC 79595
  Complete submission text file 0001193125-18-174174.txt   495809
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-222731 | Film No.: 18859590
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences